Position in ALKS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$212,324
New position
Shares Held
4,052
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#305
of 421 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Summit Financial, LLC holds $9,049,716 across 7 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
10,701 | $5,798,122 | |
| 2 | DERM |
Journey Medical Corp
|
346,748 | $2,454,975 | |
| 3 | ZTS |
Zoetis Inc.
|
4,263 | $306,339 | |
| 4 | ALKS |
Alkermes plc.
This page
|
4,052 | $212,324 | |
| 5 | VTRS |
Viatris Inc
|
10,888 | $172,901 | |
| 6 | CRDL |
Cardiol Therapeutics Inc.
|
99,109 | $105,055 | |
| 7 | ESPR |
Esperion Therapeutics, Inc.
|
85,738 | $0 |
All Filings in ALKS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $212,324 | 4,052 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||